Lupin Launches Tiotropium Dry Powder Inhaler for the Treatment of COPD in the United States
Mumbai, Baltimore, August 16, 2023: Global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment